CCN1 and sarcopenia: Furthermore, treatment of MPCs with CCN1/CYR61 induces the expression of senescence-associated β-galactosidase, a known marker for cellular senescence that can be linked to CCN1/CYR61 role in aging-related sarcopenia [44].